Meet America's Best Companies 2025 [Forbes]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Forbes
Courtesy of Vertex Pharmaceuticals Vertex Pharmaceuticals struck gold in 2011 when Incivek, its new Hepatitis C medicine, yielded $1.56 billion in sales in its first year, the fastest rise ever for a drug. But within two years, after a rival introduced a more effective treatment, that gold turned to lead. Some companies might not have recovered. But Vertex was already picking the lock on a different disease that some considered uncrackable: cystic fibrosis. Its resulting combination of three drugs, known as Trikafta, now provides effective treatment for 90 percent of patients—the latest in a series of serial innovations for the treatment and functional cure of conditions such as sickle cell disease and diabetes. "The word ‘serial' is as important as ‘innovation,' ” says Vertex president and CEO Dr. Reshma Kewalramani, of the company's approach. "More likely than not, we're going to fail for many, many years before we succeed. But we make medicines for patients, and they're wait
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals files automatic mixed securities shelf [Seeking Alpha]Seeking Alpha
- Vertex Pharmaceuticals price target raised to $520 from $460 at Truist [Yahoo! Finance]Yahoo! Finance
- AM Best Assigns Credit Ratings to Torreyana Insurance Company, Inc. [Yahoo! Finance]Yahoo! Finance
- Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast? [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 2/10/25 - Beat
VRTX
Sec Filings
- 2/14/25 - Form 4
- 2/14/25 - Form 4
- 2/14/25 - Form 4
- VRTX's page on the SEC website